MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on September 11, 2006; DOI: 10.1124/mol.106.028183


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.028183v1
70/6/2027    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dupuis, D. S
Right arrow Articles by Kaupmann, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dupuis, D. S
Right arrow Articles by Kaupmann, K.


Received for publication June 22, 2006.
Revised September 10, 2006.
Accepted for publication September 11, 2006.

Point mutations in the transmembrane region of GABAB2 facilitate activation by the positive modulator GS39783 in the absence of the GABAB1 subunit

Delphine S Dupuis 1, Dinko Relkovic 1, Loic Lhuillier 1, Johannes Mosbacher 1, Klemens Kaupmann 1*

1 Novartis Institutes for BioMedical Research

* Address correspondence to: E-mail: klemens.kaupmann{at}novartis.com

Abstract

GABAB receptors are heterodimers of two subunits, GABAB1 (GB1) and GABAB2 (GB2). Agonists such as GABA and baclofen bind to the GB1 subunit only whereas GB2 is essential for G protein activation. Positive allosteric modulators enhance the potency and efficacy of agonists at GABAB receptors and are of particular interest as they lack the sedative and muscle relaxant properties of agonists. In this study we aimed to characterize the interaction of the positive modulator GS39783 (N,N'-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine) with the GABAB receptor heterodimer. Using functional GTP{gamma}S binding assays we observed positive modulation by GS39783 in different vertebrate species but not in drosophila. However, co-expression of drosophila GB1 with rat GB2 yielded functional receptors positively modulated by GS39783. Together with data from rat/drosophila GB2 subunit chimeras, this pointed to a critical role of the GB2 transmembrane region for positive modulation. We further characterized GS39783 function using point mutations. GS39783 positively modulated GABA responses but also showed considerable agonistic activity at heterodimers containing a mutant rat GB2 subunit with three amino acids substitutions in transmembrane domain VI. Surprisingly, in contrast to wild-type rat GB2, this mutant subunit was also activated by GS39783 when expressed without GB1. The mutations of both G706T and A708P are necessary and sufficient for activation and identify a key region for the effect of GS39783 in the GB2 transmembrane region. Our data show that mutations of specific amino acids in GB2 can induce agonism in addition to positive modulation and facilitate GB2 activation in the absence of GB1.


Key words: GABAB, Gi family, Structure-activity relationships and modeling





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics